Carl Zeiss Meditec AG Provides Earnings guidance for Fiscal Year 2021 to 2022. The company estimated EBIT margin for fiscal year 2021 to 2022 to be between 19% to 21%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.4 EUR | -3.09% | -6.14% | -9.55% |
23/05 | Carl Zeiss Meditec very weak - support still holding | DP |
23/05 | Goldman downgrades Carl Zeiss Meditec to 'Sell' - Target 90 euros | DP |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.55% | 895.96Cr | |
+7.87% | 22TCr | |
+11.83% | 19TCr | |
+18.87% | 14TCr | |
+30.03% | 11TCr | |
+2.32% | 6.52TCr | |
+14.15% | 5.3TCr | |
+2.68% | 5.03TCr | |
+6.60% | 4.42TCr | |
+1.85% | 3.64TCr |
- Stock Market
- Equities
- AFX Stock
- News Carl Zeiss Meditec AG
- Carl Zeiss Meditec AG Provides Earnings Guidance for Fiscal Year 2021 to 2022